Author:
Boyce Philip,Galbally Megan,Snellen Martien,Buist Anne
Publisher
Springer Berlin Heidelberg
Reference96 articles.
1. Addis A, Koren G. Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychol Med. 2000;30(1):89–94.
2. Andrade SE, Raebel MA, Brown J, Lane K, Livingston J, Boudreau D, et al. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008;198(2):194.e1–5. doi:
10.1016/j.ajog.2007.07.036
. S0002-9378(07)00915-5 [pii].
3. Appleby L, Gregoire A, Platz C, Prince M, Kumar R. Screening women for high risk of postnatal depression. J Psychosom Res. 1994;38(6):539–45.
4. Austin MP, Hadzi-Pavlovic D, Saint K, Parker G. Antenatal screening for the prediction of postnatal depression: validation of a psychosocial Pregnancy Risk Questionnaire. Acta Psychiatr Scand. 2005;112(4):310–7. doi:
10.1111/j.1600-0447.2005.00594.x
.
5. Austin M, Highet N, GEA Committee. The beyondblue clinical practice guidelines for depression and related disorders – anxiety, bipolar disorder and puerperal psychosis – in the perinatal period. A guideline for primary care health professionals providing care in the perinatal period. Melbourne: beyondblue: the national depression initiative; 2011.